CPSC Recall in 2019: Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements

Updated on March 25, 2026.

See the recall details below. You can also see similar information for other consumer product recalls in 2019.

Data Source: CPSC.

Recall Number: 19-194

Date: August 29, 2019

Product Name: Losartan Potassium and Ezetimibe prescription drug bottles

Recall Description:

This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers.  The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The recall includes the following: Recalled Prescription DrugsNDC NumbersLot NumbersExpiration DateEzetimibe 10mg Tablets0781-5690-31JE4491Aug-202030 count bottle JE4492Aug-2020  JE4493Aug-2020  JE4495Aug-2020  JG0308Sep-2020  JG0310Sep-2020  JG0311Sep-2020  JG0312Sep-2020  JG5061Sep-2020  JG5063Sep-2020  JK8921Oct-2020  JK8922Oct-2020  JK8923Oct-2020  JK8924Oct-2020  JL5535Oct-2020  JM2253Oct-2020  JM2254Oct-2020  JM2255Oct-2020  JM2257Oct-2020  JM2258Oct-2020  JM2259Oct-2020  JM5986Oct-2020  JM5987Oct-2020Ezetimibe 10mg Tablets0781-5690-92JE4481Aug-202090 count bottle JG0249Sep-2020  JK8989Oct-2020  JN0764Jan-2021Losartan Potassium 50mg Tablets0781-5701-31HV9471Feb-202030 count bottle   

Hazard Description:

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

Consumer Action:

Remedy Type:

Replace

Units: About 636,000

Incidents:

None Reported

Sold At:

Clinics and pharmacies nationwide as a prescribed medicine from July 2018 through August 2019. The container was included in the price of the medication, which varied based on quantities prescribed, health insurance terms and other factors.

Manufactured In:

Slovenia